| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8453353 | Leukemia Research | 2018 | 15 Pages |
Abstract
CD25 was over-expressed on HSC in MDS patients, especially in high-risk MDS patients. Increased CD25+ HSC was correlated with progression of MDS. Low-expression of CD25 on erythroblasts might correlate with anemia in MDS patients. CD25 could be a specific marker of LSC in MDS, and could involve in the mechanisms of development and progression of MDS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Pei Liu, Huijuan Jiang, Mengting Che, Rong Fu, Huaquan Wang, Lijuan Li, Wei Zhang, Jinglian Tao, Shan Gao, Zonghong Shao,